TrialCancer immunology, immunotherapy : CII2021

Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-Oncology.

Sabrina Hoa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.